Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer von Dieci, M.V., Conte, P., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S., D’Amico, R., Guarneri, V.

Volltext

Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: A review von Daniele, A., Abbate, I., Oakley, C., Casamassima, P., Savino, E., Casamassima, A., Sciortino, G., Fazio, V., Gadaleta-Caldarola, G., Catino, A., Giotta, F., De Luca, R., Divella, R.

Volltext

Post-traumatic Growth in the Italian Experience of Long-term Disease-free Cancer Survivors von Cormio, C., Romito, F., Giotta, F., Mattioli, V.

Volltext

A Gradient-Based Approach for Breast DCE-MRI Analysis von Didonna, V., Lombardi, A., Guaragnella, C., Mangia, A., Massafra, R., Tamborra, P., Tangaro, Sabina, La Forgia, D., Diacono, D., Dentamaro, R., Carbonara, R., Bottigli, U., Bellotti, Roberto, Fanizzi, A., Basile, T. M. A., Losurdo, L., Giotta, F.

Volltext

Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer von Danza, K, Pilato, B, Lacalamita, R, Addati, T, Giotta, F, Bruno, A, Paradiso, A, Tommasi, S

Volltext

9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab adminis... von Conte, P.F., Guarneri, V., Bisagni, G., Piacentini, F., Brandes, A.A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Frassoldati, A., Musolino, A., Garrone, O., Taverniti, C., Rimanti, A., Sarti, S., Rubino, D., Bologna, A., Vicini, R., Balduzzi, S., D'Amico, R.

Volltext

1899 Correlation between Ki-67 and FISH testing of HER2 IHC 1+ early invasive breast cancer von Latorre, A.C, Caldarola, L, Petroni, S, Giotta, F, Lorusso, V, Trotti, I, Simone, G

Volltext

Nuclear NHERF1 expression as a prognostic marker in breast cancer von Paradiso, A, Scarpi, E, Malfettone, A, Addati, T, Giotta, F, Simone, G, Amadori, D, Mangia, A

Volltext

Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomize... von Dieci, M.V., Conte, P.F., Bisagni, G., Brandes, A.A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Omarini, C., Maiorana, A., Orvieto, E., Sanders, M., D'Amico, R., Guarneri, V.

Volltext

Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer von Conte, P., Conte, P., Bisagni, G., Frassoldati, A., Brandes, A., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Musolino, A., Garrone, O., Donadio, M., Cavazzini, G., Turletti, A., Zamagni, C., Danese, S., Ferro, A., Piacentini, F., Balduzzi, S., D'Amico, R., Guarneri, V.

Volltext

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter pha... von LORUSSO, V, GIOTTA, F, BORDONARO, R, MAIELLO, E, DEL PRETE, S, GEBBIA, V, FILIPELLI, G, PISCONTI, S, CINIERI, S, ROMITO, S, RICCARDI, F, FORCIGNANÒ, R, CICCARESE, M, PETRUCELLI, L, SARACINO, V, LUPO, L.I, GAMBINO, A, LEO, S, COLUCCI, G

Volltext

1857 Final results of a phase II study evaluating oral vinorelbine as a single-agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreas... von Steger, G.G, Dominguez, A, Dobrovolskaya, N, Giotta, F, Tubiana-Mathieu, N, Ardizzoia, A, Blasinska, M, Espinosa, E, Landreau, P, Villanova, G

Volltext

40P A survey on smoking and tobacco control perceptions from physicians and employees working in an Italian cancer center von Galetta, D., Catino, A., De Palma, M.E., Acito, A., Lacalamita, R., Longo, M., De Summa, S., Di Lauro, A., D'Ecclesiis, F., Giotta, F.

Volltext

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cance... von Vici, P., Brandi, M., Giotta, F., Foggi, P., Schittulli, F., Di Lauro, L., Gebbia, N., Massidda, B., Filippelli, G., Giannarelli, D., Di Benedetto, A., Mottolese, M., Colucci, G., Lopez, M.

Volltext

327P Monitoring over time of pathological complete response to neoadjuvant chemotherapy in breast cancer patients through an ensemble vision transformers-based model von Comes, M.C., S. bove, Fanizzi, A., Latorre, A., F. Giotta, Rizzo, A., Zito, A., Massafra, R.

Volltext

312 TROP-2 Expression and Mutation in Familiar Breast Cancer von Petroni, S, Giotta, F, Addati, T, Asselti, M, Popescu, O, Pilato, B, Marzano, A.L, Palma, F, Tommasi, S, Simone, G

Volltext

234 Metastatic Breast Cancer – a Retrospective Analysis of Abdominal/pelvic Metastasis of Breast Origin von Addati, T, Petroni, S, Caponio, M.A, Mattioli, E, Rubini, V, Digirolamo, R, Simone, G, Giotta, F

Volltext

313 HER-2/neu Overexpression as Prognostic Factor in Small Size Breast Cancer (pT1, N0, M0) von Petroni, S, Giotta, F, Asselti, M, Quero, C, Marzano, A.L, Giannone, G, Rubini, V, Simone, G

Volltext

412P Sacituzumab govitecan versus chemotherapy for metastatic breast cancer: A meta-analysis on safety outcomes von Rizzo, A., Rinaldi, L., Massafra, R., Cusmai, A., Guven, D.C., La Forgia, D., Latorre, A., Giotta, F.

Volltext

PO-38: A new armamentarium choice in cancer-associated upper-limb vein thrombosis resistant to heparin: a clinical case of seminoma in BEP chemotherapy protocol solved with edoxaba... von Fioretti, A.M., Leopizzi, T., Giotta, F., Lorusso, V., Luzzi, G., Oliva, S.

Volltext